Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Lannett CO Inc (LCI)

6.39   0.11 (1.75%) 11-29 21:40
Open: 6.23 Pre. Close: 6.28
High: 6.41 Low: 6.205
Volume: 116,380 Market Cap: 266M
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, Verapamil SR tablets, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Metolazone tablets, Amphetamine IR Tablets, Methylphenidate Hydrochloride ER stimulants, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Pharm Group, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was founded in 1942 and is headquartered in Philadelphia, Pennsylvania.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.415 - 6.445 6.445 - 6.474
Low: 6.123 - 6.157 6.157 - 6.19
Close: 6.332 - 6.388 6.388 - 6.439

Technical analysis

as of: 2020-11-29 9:24:18 AM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 7.75     One year: 8.39
Support: Support1: 5.75    Support2: 4.78
Resistance: Resistance1: 6.63    Resistance2: 7.18
Pivot: 6.26
Moving Average: MA(5): 6.26     MA(20): 6.34
MA(100): 6.12     MA(250): 7.34
MACD: MACD(12,26): -0.05     Signal(9): -0.06
Stochastic oscillator: %K(14,3): 56.85     %D(3): 44.09
RSI: RSI(14): 50.54
52-week: High: 10.34  Low: 4.89  Change(%): -26.9
Average Vol(K): 3-Month: 31968  10-Days: 24700

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
LCI has closed below upper band by 33.9%. Bollinger Bands are 39% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 24 Nov 2020
Lannett Co Inc (LCI) Soars 3.9% on November 24 - Equities.com

Tue, 24 Nov 2020
Should Value Investors Consider Lannett Company (LCI) Now? - Zacks.com

Tue, 10 Nov 2020
What is the Forecast Price for Lannett Company, Inc. (LCI) Stock? - InvestorsObserver

Tue, 10 Nov 2020
$135.78 Million in Sales Expected for Lannett Company, Inc. (NYSE:LCI) This Quarter - MarketBeat

Sat, 07 Nov 2020
Lannett Company, Inc. (NYSE:LCI) Is a Buzzing Hot Stock - Stocks Register

Fri, 06 Nov 2020
Earnings Miss: Lannett Company, Inc. Missed EPS And Analysts Are Revising Their Forecasts - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 42
Shares Float (M) 32
% Held by Insiders 23.02
% Held by Institutions 88.71
Shares Short (K) 8,440
Shares Short P. Month (K) 9,380

Stock Financials

EPS -0.710
EPS Est This Year 2.600
EPS Est Next Year 2.750
Book Value (p.s.) 7.600
Profit Margin -5.09
Operating Margin 8.70
Return on Assets (ttm) 2.6
Return on Equity (ttm) -9.0
Qtrly Rev. Growth -0.7
Gross Profit (p.s.) 4.738
Sales Per Share 13.089
EBITDA (p.s.) 2.528
Qtrly Earnings Growth
Operating Cash Flow (M) 100
Levered Free Cash Flow (M) 72

Stock Valuations

PE Ratio -9.00
PEG Ratio
Price to Book value 0.84
Price to Sales 0.49
Price to Cash Flow 2.67

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.